Open access
3,967
Views
13
CrossRef citations to date
0
Altmetric
Articles
A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy
Peter HuberPfizer Inc., Collegeville, PA, USA; View further author information
, Alison FlynnPfizer Inc., Collegeville, PA, USA; Correspondence[email protected]
View further author information
, View further author information
Marla B. SultanPfizer Inc., New York, NY, USA; View further author information
, Huihua LiPfizer Inc., Collegeville, PA, USA; View further author information
, Denise RillPfizer Inc., Collegeville, PA, USA; View further author information
, Ben EbedePfizer Inc., Collegeville, PA, USA; View further author information
, Balarama GundapaneniPfizer Inc., Groton, CT, USAView further author information
& Jeffrey H. SchwartzPfizer Inc., New York, NY, USA; View further author information
show all
Pages 203-209
|
Received 14 Nov 2018, Accepted 09 Jul 2019, Published online: 27 Jul 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.